Clinical Trial

Acute Immunological Effects of Exercise in Cancer Patients

Study acronym: ACTIVE
Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The aim of the study is to evaluate and compare immune response to a single exercise intervention in cancer patients and healthy age-maged individuals.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-12-12; most recent amendment 2026-05-12.
Status change: Recruiting → Active, Not Recruiting 2024-12-03
Status change: Not Yet Recruiting → Recruiting 2022-12-19
Trial Details
NCT Number NCT05656651
Lead Sponsor Universität Duisburg-Essen
Conditions Cancer
Enrollment 60 participants
Start Date 2022-12-19
Primary Completion 2024-07-31 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2026-05-15